|
 |
Pharmaceutical Manufacturing and Packing Sourcer
|
The next 12 months are likely to see some fundamental development in the clinical trials process with the introduction of new EC legislation and a range of new pack innovations. But despite these changes, the fundamental key to success in any clinical trial will remain the strength of partnership between sponsor and packaging supplier.
In an ideal world, the date for a clinical trial would only be set when the schedule for pack production and distribution had been agreed between sponsor and packaging supplier. In reality however, the scope of a clinical trial can be vast, with some complex studies enrolling thousands of patients in several countries around the world. Therefore, it is understandable that in practice, patients are the priority for the sponsor and the packaging process has to fit in with pre-set targets and time scales. For this reason it is vital that the sponsor involves their packaging supplier as early as is possible within the trial process and that the two develop strong lines of communication and understanding. Clinical trials are by their nature unpredictable and having a reliable supplier on board early within the process will enable a flexible and effective solution to be found.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
7th Annual Pharma Packaging and Labelling conference
17 September - 18 October 2008, Barcelona
7th Annual Pharma Packaging and Labelling conference will bring
together experts from leading pharma manufacturers to present case study driven
presentations on critical industry-wide issues.
Attending this event will give you an opportunity to discuss with fellow
packaging and labelling professionals and share your views on these important
matters.
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Product Development Group, Inc
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >> |
|
 |
